Teladoc Health Inc (NYSE:TDOC) has been given a consensus recommendation of “Buy” by the twenty-one research firms that are presently covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold recommendation, fifteen have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $85.50.

TDOC has been the subject of several analyst reports. Zacks Investment Research raised Teladoc Health from a “sell” rating to a “hold” rating in a research note on Saturday, January 26th. Cantor Fitzgerald reissued a “hold” rating and set a $83.00 target price on shares of Teladoc Health in a research note on Monday, January 7th. Chardan Capital boosted their target price on Teladoc Health from $98.00 to $100.00 and gave the stock a “buy” rating in a research note on Friday, November 2nd. Berenberg Bank initiated coverage on Teladoc Health in a research report on Thursday, January 31st. They set a “buy” rating and a $80.00 price objective for the company. Finally, Jefferies Financial Group set a $95.00 price objective on Teladoc Health and gave the stock a “buy” rating in a research report on Friday, November 2nd.

TDOC traded down $0.49 on Wednesday, hitting $69.50. 922,915 shares of the company were exchanged, compared to its average volume of 1,178,548. Teladoc Health has a twelve month low of $36.60 and a twelve month high of $89.05. The stock has a market capitalization of $4.92 billion, a price-to-earnings ratio of -42.12 and a beta of 1.47. The company has a debt-to-equity ratio of 0.40, a current ratio of 8.99 and a quick ratio of 8.99.

In other news, SVP Andrew Turitz sold 8,202 shares of the company’s stock in a transaction dated Monday, December 3rd. The stock was sold at an average price of $64.14, for a total transaction of $526,076.28. Following the completion of the transaction, the senior vice president now directly owns 9,378 shares of the company’s stock, valued at approximately $601,504.92. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Adam C. Vandervoort sold 5,550 shares of the company’s stock in a transaction dated Monday, December 10th. The stock was sold at an average price of $54.19, for a total value of $300,754.50. Following the transaction, the insider now directly owns 2,934 shares of the company’s stock, valued at $158,993.46. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 100,745 shares of company stock valued at $5,820,690. Insiders own 3.95% of the company’s stock.

Several institutional investors have recently bought and sold shares of TDOC. Vanguard Group Inc lifted its holdings in shares of Teladoc Health by 26.9% in the 3rd quarter. Vanguard Group Inc now owns 5,874,182 shares of the health services provider’s stock valued at $507,236,000 after purchasing an additional 1,244,388 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Teladoc Health by 26.9% in the 3rd quarter. Vanguard Group Inc. now owns 5,874,182 shares of the health services provider’s stock valued at $507,236,000 after purchasing an additional 1,244,388 shares during the last quarter. Capital International Investors purchased a new stake in shares of Teladoc Health in the 3rd quarter valued at about $71,239,000. Macquarie Group Ltd. raised its stake in Teladoc Health by 101.5% during the 4th quarter. Macquarie Group Ltd. now owns 1,125,275 shares of the health services provider’s stock valued at $55,780,000 after acquiring an additional 566,839 shares during the last quarter. Finally, Bellevue Group AG raised its stake in Teladoc Health by 83.1% during the 4th quarter. Bellevue Group AG now owns 1,073,839 shares of the health services provider’s stock valued at $53,230,000 after acquiring an additional 487,319 shares during the last quarter.

About Teladoc Health

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

See Also: What does RSI mean?

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.